{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:13:43Z","timestamp":1787879623805,"version":"build-2784847793"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Data on the care of Asian patients with lung cancer in the US are limited; however, lung cancer is the leading cause of cancer death in this population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Demographics, low-dose computed tomography (LDCT) screening, disease characteristics, and treatment history were compared between Asian and White patients newly diagnosed with lung cancer from 2014 to 2019 identified from Tufts Medical Center cancer registry. The influence of race on presenting stage was assessed via ordinal logistic regression. Time to treatment initiation (TTI) and overall survival (OS) were analyzed via log-rank tests. The impact of race on OS was evaluated via multivariable Cox regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Asian patients (N\u2005=\u2005144) were more likely to prefer non-English languages, use interpreters, be never-smokers, and harbor EGFR alterations, compared to White patients (N\u2005=\u2005472), and to be diagnosed with later-stage lung cancer (odds ratio: 2.14, P\u2005&amp;lt;\u2005.001), had longer median TTI (early stage: 2.30 vs. 1.43 months, P\u2005=\u2005.035; curative stage: 1.88 vs. 1.20 months, P\u2005=\u2005.041) and more often did not receive cancer-directed therapy (12.6% vs. 5.7%, P\u2005=\u2005.01). Screening LDCT was done only in 11.9% of Asian and 21.4% of White patients (P\u2005=\u2005.20) who would have met screening criteria prior to diagnosis (N\u2005=\u2005215). Median OS was similar between Asian and White patients (not reached vs. 74.8 months, P\u2005=\u2005.17). Multivariable Cox model suggested better OS for Asian patients (hazard ratio: 0.57, P\u2005=\u2005.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In our study, Asian patients presented with later-stage lung cancer, had treatment delays, and more often did not receive treatment, compared to White patients, yet did not have inferior survival.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyad272","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T18:19:05Z","timestamp":1696529945000},"page":"332-341","source":"Crossref","is-referenced-by-count":7,"title":["Screening, Diagnosis, and Initial Care of Asian and White Patients With Lung Cancer"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-8455","authenticated-orcid":false,"given":"Xiao","family":"Hu","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Tufts Medical Center , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Melson","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Tufts Medical Center , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey S","family":"Pan","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Tufts Medical Center , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana V","family":"Salei","sequence":"additional","affiliation":[{"name":"Deparment of Medicine, Tufts Medical Center , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5661-5851","authenticated-orcid":false,"given":"Yu","family":"Cao","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Tufts Medical Center , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2024041017273800900_CIT0001","author":"International Agency for Research on Cancer"},{"key":"2024041017273800900_CIT0002","volume-title":"An update on cancer deaths in the United States","author":"Centers for Disease Control and Prevention","year":"2022"},{"key":"2024041017273800900_CIT0003","author":"American Cancer Society"},{"key":"2024041017273800900_CIT0004","first-page":"330","article-title":"Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement","volume-title":"Ann Intern Med","author":"Moyer","year":"2014"},{"key":"2024041017273800900_CIT0005","first-page":"395","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume-title":"N Engl J Med","author":"Aberle","year":"2011"},{"key":"2024041017273800900_CIT0006","first-page":"764","article-title":"Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review","volume-title":"JAMA","author":"Arbour","year":"2019"},{"key":"2024041017273800900_CIT0007","first-page":"453","article-title":"Disparities in cancer care and the Asian American population","volume-title":"Oncologist","author":"Lee","year":"2021"},{"key":"2024041017273800900_CIT0008","author":"Budiman"},{"key":"2024041017273800900_CIT0009","author":"Centers for Disease Control and Prevention"},{"key":"2024041017273800900_CIT0010","first-page":"1371","article-title":"The burden of cancer in Asian Americans: a report of national mortality trends by Asian ethnicity","volume-title":"Cancer Epidemiol Biomarkers Prev","author":"Thompson","year":"2016"},{"key":"2024041017273800900_CIT0011"},{"key":"2024041017273800900_CIT0012","first-page":"811","article-title":"Smoking and lung cancer: the role of inflammation","volume-title":"Proc Am Thorac Soc","author":"Walser","year":"2008"},{"key":"2024041017273800900_CIT0013","author":"Centers for Disease Control and Prevention"},{"key":"2024041017273800900_CIT0014","first-page":"302","article-title":"Proportion of never smokers among men and women with lung cancer in 7 US States","volume-title":"JAMA Oncol","author":"Siegel","year":"2021"},{"key":"2024041017273800900_CIT0015","first-page":"450","article-title":"Lung cancer in never smokers-the East Asian experience","volume-title":"Transl Lung Cancer Res","author":"Zhou","year":"2018"},{"key":"2024041017273800900_CIT0016","first-page":"5465","article-title":"Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR","volume-title":"Oncotarget","author":"Ha","year":"2015"},{"key":"2024041017273800900_CIT0017","first-page":"53","article-title":"Current cigarette smoking among adults - United States, 2016","volume-title":"MMWR Morb Mortal Wkly Rep","author":"Jamal","year":"2018"},{"key":"2024041017273800900_CIT0018","first-page":"4247","article-title":"Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK","volume-title":"J Clin Oncol","author":"Shaw","year":"2009"},{"key":"2024041017273800900_CIT0019","first-page":"958","article-title":"Screening for epidermal growth factor receptor mutations in lung cancer","volume-title":"N Engl J Med","author":"Rosell","year":"2009"},{"key":"2024041017273800900_CIT0020","first-page":"5878","article-title":"Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas","volume-title":"Clin Cancer Res","author":"Taron","year":"2005"},{"key":"2024041017273800900_CIT0021","first-page":"960","article-title":"Cancer\/health communication and breast\/cervical cancer screening among Asian Americans and five Asian ethnic groups","volume-title":"Ethn Health","author":"Jun","year":"2020"},{"key":"2024041017273800900_CIT0022","first-page":"650","article-title":"Cancer screening behaviors and barriers in Asian Americans","volume-title":"Am J Health Behav","author":"Ma","year":"2009"},{"key":"2024041017273800900_CIT0023","first-page":"75","article-title":"Asian American cancer disparities: the potential effects of model minority health stereotypes","volume-title":"Asian Am J Psychol","author":"Ibaraki","year":"2014"},{"key":"2024041017273800900_CIT0024","first-page":"253","article-title":"The role of medical interpretation on breast and cervical cancer screening among Asian American and Pacific Islander women","volume-title":"J Cancer Educ","author":"Dang","year":"2010"},{"key":"2024041017273800900_CIT0025","first-page":"525","article-title":"New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low","volume-title":"BMC Health Serv Res","author":"Li","year":"2018"},{"key":"2024041017273800900_CIT0026","first-page":"1910","article-title":"Racial and regional disparities in lung cancer incidence","volume-title":"Cancer","author":"Underwood","year":"2012"},{"key":"2024041017273800900_CIT0027","first-page":"1938","article-title":"Advanced presentation of lung cancer in Asian immigrants: a case-control study","volume-title":"Chest","author":"Finlay","year":"2002"},{"key":"2024041017273800900_CIT0028","first-page":"4502","article-title":"Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer","volume-title":"Cancer","author":"Doebele","year":"2012"},{"issue":"2","key":"2024041017273800900_CIT0029","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/JTO.0000000000000069","article-title":"EGFR mutation and brain metastasis in pulmonary adenocarcinomas","volume":"9","author":"Shin","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2024041017273800900_CIT0030","first-page":"86","article-title":"EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases","volume-title":"Lung Cancer","author":"Hendriks","year":"2014"},{"key":"2024041017273800900_CIT0031","first-page":"287","article-title":"Stigma and its correlates in people living with lung cancer: a cross-sectional study from China","volume-title":"Psychooncology","author":"Liu","year":"2020"},{"key":"2024041017273800900_CIT0032","author":"OncLive"},{"issue":"2","key":"2024041017273800900_CIT0033","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1084822314547962","article-title":"Pain beliefs and behaviors among Chinese","volume":"27","author":"Tung","year":"2015","journal-title":"Home Health Care Manag Pract"},{"key":"2024041017273800900_CIT0034","first-page":"e202950","article-title":"Differences in stage of cancer at diagnosis, treatment, and survival by race and ethnicity among leading cancer types","volume-title":"JAMA Netw Open","author":"Zhang","year":"2020"},{"key":"2024041017273800900_CIT0035","first-page":"792","article-title":"Charting a path towards Asian American cancer health equity: a way forward","volume-title":"J Natl Cancer Inst","author":"Chen","year":"2022"},{"key":"2024041017273800900_CIT0036"},{"key":"2024041017273800900_CIT0037","first-page":"1083","article-title":"Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status","volume-title":"J Thorac Oncol","author":"Ou","year":"2009"},{"key":"2024041017273800900_CIT0038","first-page":"154","article-title":"A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)","volume-title":"J Thorac Oncol","author":"Shi","year":"2014"},{"key":"2024041017273800900_CIT0039","first-page":"438","article-title":"EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey","volume-title":"J Thorac Oncol","author":"Yatabe","year":"2015"},{"key":"2024041017273800900_CIT0040","first-page":"287","article-title":"East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians","volume-title":"Chin J Cancer","author":"Zhou","year":"2011"},{"key":"2024041017273800900_CIT0041","first-page":"e0143515","article-title":"Molecular epidemiology of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology - mainland China subset analysis of the PIONEER study","volume-title":"PLoS One","author":"Shi","year":"2015"},{"key":"2024041017273800900_CIT0042","first-page":"239","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume-title":"Lancet Oncol","author":"Rosell","year":"2012"},{"key":"2024041017273800900_CIT0043","first-page":"S23","article-title":"EGFR first- and second-generation TKIs-there is still place for them in EGFR-mutant NSCLC patients","volume-title":"Transl Cancer Res","author":"Karachaliou","year":"2019"},{"key":"2024041017273800900_CIT0044","first-page":"41","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume-title":"N Engl J Med","author":"Ramalingam","year":"2020"},{"key":"2024041017273800900_CIT0045","first-page":"1823","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume-title":"N Engl J Med","author":"Reck","year":"2016"},{"key":"2024041017273800900_CIT0046","volume-title":"Immunotherapy for lung cancer","author":"Cancer Research Institute"},{"key":"2024041017273800900_CIT0047","first-page":"1362","article-title":"Immune checkpoint inhibitors for lung cancer treatment: a review","volume-title":"J Clin Med","author":"Onoi","year":"2020"},{"key":"2024041017273800900_CIT0048","first-page":"2342","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume-title":"N Engl J Med","author":"Antonia","year":"2018"},{"key":"2024041017273800900_CIT0049","first-page":"1301","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume-title":"J Clin Oncol","author":"Spigel","year":"2022"},{"key":"2024041017273800900_CIT0050","first-page":"1781333","article-title":"A meta-analysis comparing responses of Asian versus non-Asian cancer patients to PD-1 and PD-L1 inhibitor-based therapy","volume-title":"Oncoimmunology","author":"Peng","year":"2020"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/4\/332\/57210387\/oyad272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/4\/332\/57210387\/oyad272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T18:15:32Z","timestamp":1712772932000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/29\/4\/332\/7292101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,10,5]]},"published-print":{"date-parts":[[2024,4,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyad272","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2023,10,5]]}}}